Nippon Shinyaku Ordered to Pay $115 Million in Landmark Patent Infringement Case with Sarepta Therapeutics

Nippon Shinyaku Co. Ltd. has been ordered to pay over $115 million to Massachusetts-based Sarepta Therapeutics following a ruling by a federal jury in Delaware. The jury determined that Nippon Shinyaku infringed on a patent owned by Sarepta and failed to invalidate the patent claims, solidifying the financial obligation of the Japanese company. This verdict underscores the complexities of intellectual property disputes, particularly in the biopharmaceutical sector, where proprietary technologies are fiercely protected to maintain competitive advantage and advance medical innovation. For further details on the case, visit the original article on Law360.